2m 2m 2m 2m 2m 2m 2m
PELTHOS THERAP (PTHS)
NYSE
$19.79+$0.20 (+1.00%)
Price as of Oct 22, 2026 4:25 PM EDT- $71.6MMarket Cap
- -43.35%1-Year Change
- BiotechnologyIndustry
PELTHOS THERAP (PTHS)
$19.79+$0.20 (+1.00%)
PTHS | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $19.59 | ||
Change | -$1.80 (-8.78%) | ||
Open | $19.21 | ||
High | $20.29 | ||
Low | $19.21 | ||
Previous Close | $18.70 | ||
Volume | 79,803 | ||
30-Day Average Volume | 43,894 | ||
1-Week Change | -7.65% | ||
1-Month Change | -19.22% | ||
1-Year Change | -43.35% | ||
3-Year Change | N/A | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 3.8M | ||
Total Assets | $137.4M | ||
Market Cap | $71.6M | ||
Enterprise Value | $130.0M | ||
Period: QTR TTM FY | |||
Revenue | $15.4M | ||
Net Income | -$23.4M | ||
Free Cash Flow | -$7.7M | ||
EBIT | -$23.0M | ||
EBITDA | -$22.0M | ||
Net Working Capital | $31.4M | ||
EPS | -$6.62 | ||
Enterprise Value/EBITDA | -6 | ||
Enterprise Value/Revenue | 8 | ||
P/B | -48 | ||
P/E | -3 | ||
PEG | -0 | ||
Price/Free Cash Flow | -9 | ||
Price/Operating Cash Flow | -9 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue